CAS 1575818-46-0

Fórmula: C28H35F2N5O2S

InChI: InChI=1S/C28H35F2N5O2S/c1-6-24(36)34-13-7-8-19(34)16-35-21-10-9-18(15-31-17(2)28(3,4)5)14-20(21)32-27(35)33-26(37)23-12-11-22(38-23)25(29)30/h6,9-12,14,17,19,25,31H,1,7-8,13,15-16H2,2-5H3,(H,32,33,37)/t17-,19+/m0/s1

Clave InChI: NXTKFBGDLDPFLB-PKOBYXMFSA-N

SMILES: C[C@@H](C(C)(C)C)NCC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC=C(S3)C(F)F)C[C@H]4CCCN4C(=O)C=C

PRN 694

CAS: 1575818-46-0

PRN 694

Fórmula: C₂₈H₃₅F₂N₅O₂S

Pureza: 99.36%

Peso molecular: 543.67

Ref: 54-PC1032621

PRN 694

CAS: 1575818-46-0

Fórmula: C₂₈H₃₅F₂N₅O₂S

Pureza: 99.36%

Forma y color: Solid

Peso molecular: 543.6716

Ref: IN-DA01EO77

PRN694

CAS: 1575818-46-0

PRN694 is a selective covalent ITK/RLK inhibitor with extended target residence time that suppresses T-cell activation, cytokine release, Th1/Th17 responses, and inflammatory disease phenotypes in preclinical models.

Fórmula: C₂₈H₃₅F₂N₅O₂S

Pureza: 98%

Forma y color: Solid

Peso molecular: 543.672

Ref: TM-T16578